3 Topic Commentaries
Addressing the Unanswered Questions in Myopia Management
-
Lori Ann F. Kehler, OD; David K. Wallace, MD, MPH, OD; MD, MPH
Ophthalmology & Visual Sciences
•Vanderbilt Eye Institute, Vanderbilt University Medical Center
SourceVarious interventions for slowing progressive myopia have been described, including antimuscarinic eye drops, bifocal spectacle lenses, multifocal contact lenses, novel special lens designs, orthokeratology, outdoor activities, and red light therapy, yet no singular treatment has emerged as a gold standard with lasting effects.
-
Michael X. Repka, MD, MBA, MD, MBA
Pediatric Ophthalmology
•Wilmer Eye Institute, Johns Hopkins University School of Medicine
SourceHowever, at this time, the reduction in rate of complications suggested from cross-sectional analyses has not been shown in randomized clinical studies of myopia, which will require decades to complete.
-
Lisa Ostrin, OD, PhD, OD, PhD
Vision Science
•University of Houston College of Optometry
SourceRed light therapy has shown excellent efficacy in controlling axial elongation and myopia progression in children; however, we must carefully assess its safety, as continuous exposure to high-intensity light could pose risks to the retina.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


